Labcorp Holdings vs Roivant Sciences

Labcorp Holdings (LH), health care, and Roivant Sciences (ROIV), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Labcorp Holdings is worth $29.9B on the stock market and Roivant Sciences $28B: Labcorp Holdings is valued at 7% more. Labcorp Holdings's operating margin in its latest fiscal year was 9.92% and Roivant Sciences's -6236%. Over the past year Labcorp Holdings's share price has moved +43.4% and Roivant Sciences's +88.2%.

Key facts

Labcorp Holdings market value
$29.9B
Roivant Sciences market value
$28B
Labcorp Holdings P/E
30.2
Labcorp Holdings revenue
$14BFY to 2025-12-31
Roivant Sciences revenue
$8.3MFY to 2026-03-31
Superinvestors holding both
0

Market values as of .

Labcorp Holdings vs Roivant Sciences: every measure side by side
Measure Labcorp Holdings Roivant Sciences
SectorHealth CareHealth Care
Country United States United Kingdom
Fiscal year ends2025-12-312026-03-31
Size
Market cap$29.9Bhigher$28Blower
Revenue$14Bhigher$8.3Mlower
Earnings$876.5Mhigher-$299.8Mlower
Employees71,000higher721lower
Total assets$18.4Bhigher$5.7Blower
Valuation
P/E30.2—
P/S2.1lower3396higher
P/B3.4—
Dividend yield0.77%—
Profitability
Operating margin9.92%higher-6236%lower
Balance sheet
Net assets$8.6Bhigher$4.5Blower
Total liabilities$9.8Bhigher$416.3Mlower
Total debt$5.6B—
Cash on hand$532.3Mlower$1.4Bhigher
Price change
Today-1.13%lower+0.26%higher
1 year+43.4%lower+88.2%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

Percentages are each holding's share of that investor's reported portfolio. Who owns LH · Who owns ROIV

Further comparisons

Learn

Questions and answers

Which is bigger, Labcorp Holdings or Roivant Sciences?

By market value, Labcorp Holdings is the larger: $29.9B against $28B for Roivant Sciences. By revenue in its latest fiscal year, Labcorp Holdings is the larger: $14B against $8.3M for Roivant Sciences.

Which has the higher operating margin?

Labcorp Holdings: 9.92%, against -6236% for Roivant Sciences. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both Labcorp Holdings and Roivant Sciences?

None of the tracked superinvestors holds both in their latest 13F filing. 7 hold Labcorp Holdings and 6 hold Roivant Sciences.

Cite this page

Funkfolio, “Labcorp Holdings vs Roivant Sciences”, data as of 18 November 2026. https://funkfolio.com/compare/lh-vs-roiv

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.